13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC
ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 29 holding rows worth $135,712,625.
- Accession
- 0001085146-23-003446
- Filer
- CIK 1012622
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 29 entries on the cover page, a total value of $135,712,625 stated on the cover page (in dollars after the unit check, H1), rows summing to $135,712,625 with VALUE read as dollars as filed, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 2,015,495 | $26,806,084 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 245,495 | $20,341,716 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 597,773 | $14,298,730 | dollars as filed | |
| OPKO HEALTH INC | 68375N103 | COM | 4,242,465 | $9,206,149 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A900 | COM | 175,000 | $7,873,250 | dollars as filed | call |
| PACIFIC BIOSCIENCES CALIF IN | 69404D908 | COM | 515,100 | $6,850,830 | dollars as filed | call |
| QUIDELORTHO CORP | 219798905 | CALL | 82,200 | $6,811,092 | dollars as filed | call |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 152,600 | $5,513,438 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 865,849 | $5,160,460 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 3,056,460 | $4,890,336 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y909 | COM | 64,500 | $4,076,400 | dollars as filed | call |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 555,522 | $3,910,875 | dollars as filed | |
| FORIAN INC | 34630N106 | cs | 1,364,329 | $3,342,606 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 41,377 | $2,615,026 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 699,700 | $2,371,983 | dollars as filed | |
| IMMUTEP LTD | 45257L108 | SPONSORED ADS | 894,391 | $1,887,165 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T905 | COM | 50,000 | $1,806,500 | dollars as filed | call |
| Accelerate Diagnostics | 00430H102 | COM | 1,510,654 | $1,223,630 | dollars as filed | |
| BIOHAVEN LTD | G1110E907 | COM | 48,600 | $1,162,512 | dollars as filed | call |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 197,449 | $1,105,714 | dollars as filed | |
| FIBROGEN INC | 31572Q908 | CALL | 277,000 | $747,900 | dollars as filed | call |
| BIOGEN INC COM | 09062X103 | Stock | 2,412 | $687,058 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 15,000 | $674,850 | dollars as filed | |
| VERTEX ENERGY INC | 92534K107 | COM | 100,400 | $627,500 | dollars as filed | |
| Palantir Technologies Inc. Class A | 69608A108 | COM | 36,700 | $562,611 | dollars as filed | |
| OPKO HEALTH INC | 68375N903 | COM | 236,800 | $513,856 | dollars as filed | call |
| PROSHARES TR | 74347X831 | ULTRAPRO QQQ | 70,000 | $414,400 | dollars as filed | |
| DERMTECH INC | 24984K105 | COM | 47,687 | $123,986 | dollars as filed | |
| INKT | 603693102 | Stock | 50,461 | $105,968 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-23-003446 | this filing | 2023-08-14 | acceptance time not in the bulk data set |